Benefit with anti-PD-L1

被引:0
|
作者
Diana Romero
机构
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:71 / 71
相关论文
共 50 条
  • [21] Product review: avelumab, an anti-PD-L1 antibody
    Collins, Julie M.
    Gulley, James L.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 891 - 908
  • [22] PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
    Naoya Maekawa
    Satoru Konnai
    Maki Nishimura
    Yumiko Kagawa
    Satoshi Takagi
    Kenji Hosoya
    Hiroshi Ohta
    Sangho Kim
    Tomohiro Okagawa
    Yusuke Izumi
    Tatsuya Deguchi
    Yukinari Kato
    Satoshi Yamamoto
    Keiichi Yamamoto
    Mikihiro Toda
    Chie Nakajima
    Yasuhiko Suzuki
    Shiro Murata
    Kazuhiko Ohashi
    npj Precision Oncology, 5
  • [23] Improving efficacy and reducing toxicity of anti-PD-L1 treatment: T-cells as delivery vehicles for anti-PD-L1 blocking nanobodies
    Petit, P-F.
    Zhu, J.
    van den Eynde, B. J.
    ANNALS OF ONCOLOGY, 2020, 31 : S1425 - S1425
  • [24] PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
    Maekawa, Naoya
    Konnai, Satoru
    Nishimura, Maki
    Kagawa, Yumiko
    Takagi, Satoshi
    Hosoya, Kenji
    Ohta, Hiroshi
    Kim, Sangho
    Okagawa, Tomohiro
    Izumi, Yusuke
    Deguchi, Tatsuya
    Kato, Yukinari
    Yamamoto, Satoshi
    Yamamoto, Keiichi
    Toda, Mikihiro
    Nakajima, Chie
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [25] ANTI-PD-1 AND ANTI-PD-L1 ANTIBODIES AS IMMUNOTHERAPY AGAINST CANCER: A STRUCTURAL PERSPECTIVE
    Cordova-Bahena, Luis
    Velasco-Velazquez, Marco A.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (01): : 8 - 16
  • [26] Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
    Kathryn Lurain
    Ramya Ramaswami
    Robert Yarchoan
    Thomas S. Uldrick
    Current HIV/AIDS Reports, 2020, 17 : 547 - 556
  • [27] Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer
    Lurain, Kathryn
    Ramaswami, Ramya
    Yarchoan, Robert
    Uldrick, Thomas S.
    CURRENT HIV/AIDS REPORTS, 2020, 17 (05) : 547 - 556
  • [28] Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies
    Boustani, Jihane
    Lecoester, Benoit
    Baude, Jeremy
    Latour, Charlene
    Adotevi, Olivier
    Mirjolet, Celine
    Truc, Gilles
    CANCERS, 2021, 13 (19)
  • [29] Effect of NK cell treatment on PD-L1 expression and anti-PD-L1 response
    Copik, Alicja
    Oyer, Jeremiah
    Gitto, Sarah
    Altomare, Deborah
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [30] Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
    Gao, Tian
    Mao, Zheng
    Li, Wenjing
    Pei, Renjun
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (03) : 746 - 756